Transparency data

Clinical trials for medicines: authorisation assessment performance

Data on the time taken by MHRA to assess clinical trial applications and substantial amendments.

Documents

Clinical trials data for medicines

Details

This data sets out the number of applications assessed by MHRA, split by phase and commercial and non-commercial sponsors.

The phase of application matches with the phases described in The Medicines (Products for Human Use) (Fees) Regulations and not the phase described in the application form.

Data is also provided for substantial amendments, split by phase. Monthly data is determined by the date initial assessment was completed, and not the receipt date.

Published 12 February 2015
Last updated 7 August 2018 + show all updates
  1. Updated Clinical trials data for medicines document
  2. Uploaded new clinical trials data for medicines document.
  3. Updated CTU metrics for medicines.
  4. Added Feb 2018 CTU PDF
  5. CTU metrics for December 2017 added to the page.
  6. Updated attachment for October and November
  7. CTU metrics for September added to the page.
  8. CTU metrics for August added to the page.
  9. CTU metrics up to July 2017 added to the page.
  10. CTU metrics updated for June 2017
  11. Clinical Trials metrics for May 2017 added to the page.
  12. Updated clinical trials data added for March
  13. Updated metrics for clinical trials
  14. updated metrics
  15. Added November updates for CTU metrics.
  16. Latest CTU metrics for October added.
  17. Updated metrics
  18. updated data
  19. Added July updates for CTU metrics.
  20. Added June updates for CTU metrics
  21. Added May updates for CTU metrics
  22. Additional data up to March 2016
  23. Updated: Clinical trials for medicines: authorisation assessment performance
  24. Clinical trials for medicines: authorisation assessment performance (April 2014 to March 2015)
  25. Clinical trials authorisation assessment performance has been updated.
  26. First published.